Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants

Clinical trial NCT07249320 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07249320
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Respiratory Syncytial Virus (RSV)

Start date: 2025-12-01
Primary completion: 2027-09-30
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.